LA JOLLA—Salk Institute scientists have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.6 million Americans with a cost of $14.4 billion annually.
The post First immune-evading cells created to treat type 1 diabetes appeared first on Salk Institute for Biological Studies.
